Favipiravir
Showing 26 - 50 of 91
COVID Trial in Melbourne (Favipiravir)
Active, not recruiting
- COVID
- Favipiravir
-
Melbourne, Victoria, AustraliaAlfred Health
Oct 6, 2021
COVID Trial in Tanta (Favipiravir, Chloroquine)
Completed
- COVID
- Favipiravir
- Chloroquine
-
Tanta, EgyptTanta University, Ainshams University
Oct 29, 2021
SARS-CoV2, COVID-19 Trial in Ankara, Istanbul (Ribavirin Capsules, Favipiravir)
Not yet recruiting
- SARS-CoV2
- COVID-19
- Ribavirin Capsules
- Favipiravir
-
Ankara, Cebeci, Turkey
- +3 more
Apr 1, 2021
COVID-19 Trial in Mansoura (Casirivimab and Imdevimab Drug Combination, Remdesivir, Favipiravir)
Completed
- COVID-19
- Casirivimab and Imdevimab Drug Combination
- +2 more
-
Mansoura, El-dkhalia, EgyptEl-gomhoria St
Aug 13, 2022
Sars-CoV2, COVID-19 Trial in Ankara (Favipiravir (3200 mg + 1200 mg), Favipiravir (3600 mg + 1600 mg), Favipiravir (3200 mg +
Active, not recruiting
- Sars-CoV2
- COVID-19
- Favipiravir (3200 mg + 1200 mg)
- +5 more
-
Ankara, TurkeyHacettepe University, School of Medicine
Jan 29, 2021
Favipiravir in Treatment of COVID-19 Patients Over 15 Years of
Active, not recruiting
- COVID-19
- Favipiravir
-
Ankara, TurkeyHacettepe University, School of Medicine
Jan 29, 2021
COVID-19 Respiratory Infection, FLU, Cold; Influenza Trial in Kayseri (Kunamin®, Favipiravir, Enoxaparin)
Completed
- COVID-19 Respiratory Infection
- +4 more
- Kunamin®
- +6 more
-
Kayseri, Kayseri Province, TurkeyKayseri City Hospital
Jun 10, 2022
Covid19 Trial in Kathmandu, Pokhara (Favipiravir, Placebo, Remdesivir)
Recruiting
- Covid19
- Favipiravir
- +2 more
-
Kathmandu, Bagmati, Nepal
- +1 more
Jan 3, 2021
COVID-19 Trial in Minas Gerais, Bangkok, Samut Prakan (Favipiravir, Monoclonal antibodies, Ivermectin)
Recruiting
- COVID-19
- Favipiravir
- +4 more
-
Minas Gerais, Brazil
- +3 more
Feb 4, 2022
Covid19 Trial in South Africa, United Kingdom (CST-2: EIDD-2801, CST-2: Placebo, Nitazoxanide)
Recruiting
- Covid19
- CST-2: EIDD-2801
- +6 more
-
Cape Town, South Africa
- +5 more
Aug 9, 2022
Covid19 Trial in Jakarta (Favipiravir, Oseltamivir 75mg)
Unknown status
- Covid19
- Favipiravir
- Oseltamivir 75mg
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangunkusumo National Referral Hospital
Sep 21, 2020
Favipiravir on Mortality in COVID-19 atTertiary Center Intensive
Completed
- Mortality
- Intensive Care Unit
-
Istanbul, TurkeySisliHamidiye Etfal Education and Training Hospital
Nov 25, 2020
COVID-19 Trial in Johannesburg (Standard of care (Paracetamol), Artesunate-amodiaquine, Pyronaridine-artesunate)
Completed
- COVID-19
- Standard of care (Paracetamol)
- +4 more
-
Johannesburg, South AfricaEzintsha, Wits Reproductive Health & HIV Institute University of
Sep 16, 2021
Covid19 Trial in Brazil, Mexico, United States (Favipiravir, Placebo)
Completed
- Covid19
- Favipiravir
- Placebo
-
Pelham, Alabama
- +37 more
Nov 29, 2021
COVID-19 Trial in Russian Federation (Favipiravir, Standard of care)
Completed
- COVID-19
- Favipiravir
- Standard of care
-
Moscow, Russian Federation
- +4 more
Nov 3, 2020
Bioequivalence Trial in Akyurt, Sahinbey (FAVICOVIR 200 mg Film Tablet, AVIGAN 200 mg Film Tablets)
Completed
- Bioequivalence
- FAVICOVIR 200 mg Film Tablet
- AVIGAN 200 mg Film Tablets
-
Akyurt, Ankara, Turkey
- +1 more
Aug 13, 2020
Bioequivalence Trial in Akyurt, Sahinbey (Test: Favipiravir 200 mg (LOQULAR), Reference: Favipiravir 200 mg (Avigan))
Completed
- Bioequivalence
- Test: Favipiravir 200 mg (LOQULAR)
- Reference: Favipiravir 200 mg (Avigan)
-
Akyurt, Ankara, Turkey
- +1 more
Aug 8, 2020
Coronavirus Disease (COVID-19) Trial in Cairo (favipiravir, Standard of care therapy)
Completed
- Coronavirus Disease (COVID-19)
- favipiravir
- Standard of care therapy
-
Cairo, Non-US, EgyptFaculty of Medicine Ain Shams University Research Institute- Cli
Jun 24, 2020
COVID-19, Favipiravir, Kaletra Trial in Tehran (Favipiravir, Hydroxychloroquine, Lopinavir / Ritonavir)
Completed
- COVID-19
- +4 more
- Favipiravir
- +2 more
-
Tehran, Iran, Islamic Republic ofMohammad Sadegh Bagheri Baghdasht
Jun 12, 2020
COVID-19, Favipiravir (Favipira) Trial in Dhaka (Favipiravir, Only Standard Treatment)
Recruiting
- COVID-19
- Favipiravir (Favipira)
- Favipiravir
- Only Standard Treatment
-
Dhaka, BangladeshMahanagar General Hospital, Dhaka (Site-1), Mugda Medical Colleg
May 22, 2020
COVID-19 Trial in Tehran (Favipiravir, Hydroxychloroquine)
Unknown status
- COVID-19
- Favipiravir
- Hydroxychloroquine
-
Tehran, Iran, Islamic Republic ofShahid Modarres Hospital, Shahid Beheshti University of Medical
Apr 26, 2020
COVID-19 Trial in Milano (Favipiravir, Placebo)
Unknown status
- COVID-19
- Favipiravir
- Placebo
-
Milano, ItalyAsst Fatebenefratelli Sacco
Apr 7, 2020
Bioequivalence Trial in Akyurt (AVICOD 200 MG Film Tablet, AVIGAN 200 MG Film Tablets)
Active, not recruiting
- Bioequivalence
- AVICOD 200 MG Film Tablet
- AVIGAN 200 MG Film Tablets
-
Akyurt, Ankara, TurkeyNovagenix Drug R&D Center
Nov 26, 2020
COVID-19 Trial in Beijing, Wuhan (Favipiravir Combined With Tocilizumab, Favipiravir, Tocilizumab)
Unknown status
- COVID-19
- Favipiravir Combined With Tocilizumab
- +2 more
-
Beijing, Beijing, China
- +5 more
Apr 8, 2020